Skip to main content
PLOS One logoLink to PLOS One
. 2020 Sep 3;15(9):e0237422. doi: 10.1371/journal.pone.0237422

Male childlessness as independent predictor of risk of cardiovascular and all-cause mortality: A population-based cohort study with more than 30 years follow-up

Angel Elenkov 1,2,*, Aleksander Giwercman 1,2, Sandra Søgaard Tøttenborg 3, Jens Peter Ellekilde Bonde 3,4, Clara Helene Glazer 5, Katia Keglberg Haervig 3, Ane Berger Bungum 3, Peter M Nilsson 6
Editor: Ying-Mei Feng7
PMCID: PMC7470262  PMID: 32881896

Abstract

In a recent population-based study, an elevated risk of the Metabolic syndrome (MetS) and type 2 diabetes was found in childless men compared to those who have fathered one or more children. Therefore, by using a larger cohort of more than 22 000 men from the Malmo Preventive Project (MPP) we aimed to expand our observations in order to evaluate the metabolic profile of childless men and to evaluate if childlessness is an additional and independent predictor of major adverse cardiovascular events (MACE), mortality and incident diabetes when accounting for well-known biochemical, anthropometric, socio-economic and lifestyle related known risk factors. Logistic regression was used to assess risk of MACE, diabetes and MetS at baseline. Multivariate Cox regression was used to evaluate the risks of MACE and mortality following the men from baseline screening until first episode of MACE, death from other causes, emigration, or end of follow-up (31st December 2016) adjusting for age, family history, marital status, smoking, alcohol consumption, educational status, body mass index, prevalent diabetes, high blood lipids, increased fasting glucose and hypertension. Childless men presented with a worse metabolic profile than fathers at the baseline examination, with elevated risk of high triglycerides, odds ratio (OR) 1.24 (95%CI: 1.10–1.42), high fasting glucose OR 1.23 (95%CI: 1.05–1.43) and high blood pressure, OR 1.28 (95%CI: 1.14–1.45), respectively. In the fully adjusted prospective analysis, childless men presented with elevated risk of cardiovascular mortality, HR: 1.33 (95% CI: 1.18–1.49) and all-cause mortality, HR 1.23 (95%CI: 1.14–1.33), respectively. In conclusion, these results add to previous studies showing associations between male reproductive health, morbidity and mortality. Male childlessness, independently of well-known socio-economic, behavioral and metabolic risk factors, predicts risk of cardiovascular disease and mortality. Consequently, this group of men should be considered as target population for preventive measures.

Introduction

In recent years, studies from the United States and Europe have shown associations between impaired male reproductive health and risk of various non-communicable adult-onset diseases. Low sperm counts have been associated with higher risk of type 2 diabetes, metabolic syndrome (MetS) and all-cause mortality [14]. It has also been shown that men who fathered children following intracytoplasmic sperm injection (ICSI)–which is the preferred method when semen quality is poor—more often is prescribed drug treatment for hypertension, dyslipidemia, and MetS [5]. Married men who have not fathered children, which might reflect impaired fertility, have presented with higher risk of diabetes and cardiovascular disease [6, 7]. Therefore, a man’s reproductive performance was suggested to be a general health marker [4].

The biological link between impaired male reproductive function and general health is complex and probably includes an interplay between genetic and environmental factors possibly operating as early as during intrauterine life [811]. As a consequence, testicular insufficiency and testosterone deficiency may serve as a possible mediator between these associations [1215]. Since family size is often influenced by fecundity, men with lower offspring number (i.e. one child or childless) may represent a group with overrepresentation of testicular dysfunction [6, 16, 17].

In a recent study of 2572 Swedish men, an elevated risk of MetS and type 2 diabetes was found in childless men as compared to those men who have fathered one or more children [7]. Having access to a larger cohort of men from background population and a longer follow-up, we wanted to evaluate the metabolic profile of childless men and estimate the risks of major adverse cardiovascular events (MACE) and cardiovascular and all-cause mortality accounting for well known risk factors of cardiovascular disease (CVD) including smoking, alcohol consumption, high body mass index (BMI), dyslipidemia, hypertension, family history of CVD high fasting glucose, and socioeconomic factors. The aim was to investigate whether male childlessness per se predicted an additional risk increase. Since previous research has pointed to different causation as considering stroke events [18] a separate end point was evaluated excluding the latter from the composite MACE end point (referred to as non-stroke MACE).

Subjects and methods

Study population

Data for this study was obtained from the Malmo Preventive Project (MPP). The original project was designed to screen for cardiovascular risk factors and alcohol overuse in the background population living in Malmo, southern Sweden. Baseline examination was conducted between 1974 and 1984 at the Department of Preventive Medicine, Malmo University Hospital [19]. A total of 22 444 men aged 25 to 63 years were recruited with a participation rate of approximately 71%.

The physical examination and laboratory investigations have previously been described in detail [1921]. In brief, all subjects were examined for weight (kg) and height (m), and body mass index (BMI; kg/m2) was calculated. Blood pressure was measured in mmHg after 10 minutes’ rest. Blood samples were drawn after an overnight fast and analyzed for fasting blood glucose, total serum cholesterol, and serum triglycerides using standard methodology at the Department of Clinical Chemistry. A self-administered questionnaire with 260 questions focusing on family and medical history, as well as lifestyle (smoking habits, physical activity), and educational level was completed.

Information on paternal status

Information regarding paternal status was gathered using two sources: (a) the baseline questionnaire where men answered “yes” or “no” to the question “Do you have children? and (b) the Swedish Tax Agency Statistics (STAS) which presents the number of children and their personal ID (date of birth) to each father as a consecutive number linking data using unique personal identification code assigned to all Swedish citizens. The data was last updated at the end of follow up (31st December 2016).

The study has been approved by the Regional Ethics Review Board at Lund University (85/2004) and complies with the declaration of Helsinki. Participants gave informed consent.

Retrieval of cardiovascular disease endpoints and mortality

Information on deaths and cardiovascular events during follow-up were obtained through cross-linking the cohort members with the following population registers: The Swedish National Hospital Discharge Register, the Swedish National Coronary Angiography and Angioplasty Registry (SCAAR), the Swedish National Cause of Death Register (SNCDR), the local Stroke Register in Malmo, and the National Swedish Classification Systems of Surgical Procedures. The registers have recently been validated for classification of outcomes and found to be of high quality with validity 86–97% [22]. Information on mortality including age and date of death were retrieved from SNCDR.

Cardiovascular mortality was defined as a separate end point deriving data from SNCDR.

MACE was defined as fatal or non-fatal myocardial infarction, fatal or non-fatal stroke, death due to ischemic heart disease, coronary artery bypass graft surgery (CABG), or percutaneous coronary intervention (PCI). Transient ischemic attack was not included as a stroke event.

Non-stroke MACE was defined as a separate endpoint in order to determine whether childlessness modifies the risk of other types of MACE except stroke events [18].

Data for the aforementioned endpoints was sourced as follows: Myocardial infarction was defined on the basis of ICD-9 code 410 and ICD-10 code I21; Death due to cardiovascular disease (CVD) was defined on the basis of codes 412 or 414 (ICD-9) and I22–I23 or I25 (ICD-10); CABG was identified from national Swedish classification systems of surgical procedures and defined as procedure codes 3065, 3066, 3068, 3080, 3092, 3105, 3127, or 3158 (the Op6 system) or procedure code FN (the KKÅ97 system); PCI was identified from SCAAR. Stroke was defined on the basis of codes 430–432, or 434 (ICD-9) and code I60-I63 (ICD-10).

Identification of diabetes

In total, 15 different sources of data were used to identify individuals with diabetes. All individuals in the following registers were searched: Diabetes 2000 (except certain with missing data), the All New Diabetes cases in Scania (ANDIS), and the Swedish National Diabetes Register (SNDR) were considered to have diabetes, as well as men with at least two HbA1c-values ≥6.0% (not on the same day) in the HbA1c register at Department of Clinical Chemistry, Malmö. In the National Patient Register (inpatient care and outpatient care) and the Swedish Cause of Death Register from the National Board of Health and Welfare, individuals with the ICD10 codes E10-E14 and O244-O249 (and corresponding ICD7-9 codes), were treated as men with diabetes. The ATC code A10 was used to identify individuals with diabetes in the Prescribed Drug Register. Further, men who in the baseline examination had fasting blood glucose ≥ 5.6, or post-load glucose ≥11 mmol/L at 120 minutes oral glucose tolerance test, or had reported intake of ACT category A10 drugs, or have responded “Yes” on the question “Do you have diabetes?” was considered to have diabetes.

Co-variates and data retrieval

Data on marital status (never-married; married; divorced; widowed), number of cigarettes per day (none; 1–10;10–20;30–40; 40 or more), and educational level (no education; primary school; secondary school or more) was derived from the baseline questionnaire. A positive family history for CVD was defined as reporting having at least one first-degree relative with MI before the age of 60 years as described previously [23]. No family history was defined as no reported first‐degree relatives with MI before 60 or no answer in the questionnaire. The co-variate “alcohol consumption” was determined based on questions on alcohol habits according to “Malmo modification of the brief Michigan Alcohol Screening Test” (Mm-MAST). It is described elsewhere and contains seven questions [24]. The questions analyzed aim to give a quantitative measure of the risk habits associated with alcohol consumption. They were divided into two categories containing confirmative answers to three questions each. ‘‘Moderate risk alcohol habits” includes the following three questions: ‘‘Do you usually have a drink before going to a party?, ‘‘Do you mostly drink alcohol, e.g. a bottle of wine, at weekends or holidays?, and ‘‘Do you drink a couple of beers, some glasses of wine or a drink to relax on a daily basis?. The category ‘‘heavy risk alcohol habits” includes the following three questions: ‘‘Do you tolerate liquor better now than 10 years ago?, ‘‘Has it ever happened that after a party you do not remember how you got into bed?, and ‘‘Do you usually have bad consciousness after a party?” If the answer was ‘‘yes” to one or more of the questions included in either of the two drinking categories the total answer to that category was considered as ‘‘yes”. If the answer was “no” to all of the abovementioned question the subject was classified to third category—“low risk alcohol consumption”. Three separate MetS components were selected as continuous co-variates: fasting blood glucose, triglycerides, blood pressure after 10 minutes rest, available from the baseline screening.

Statistical methods

Baseline morbidity

We categorized a man as childless if he answered “no” in the questionnaire and had no registered children in STAS. Men who answered “yes” in the questionnaire and/or had children registered in STAS were categorized as fathers. Men with missing data in both the questionnaire and STAS were excluded, as were men who answered “no” in the questionnaire but had STAS registered children before the entry date (conflicting information).

Baseline characteristics were compared by T-test for continuous variables and Chi-square test for categorical. The associations between childlessness and high fasting glucose, high blood pressure, and high triglycerides were assessed using logistic regression analyses. NCEP III criteria were used to determine the threshold values [25]. To account for possible confounding, the models were adjusted for age, marital status, educational level, BMI, alcohol consumption and smoking.

Prevalent diabetes and MACE risks were evaluated at baseline using the same methodology as described above.

Prospective analysis

The risk of having an incident MACE was evaluated using multivariate Cox regression and presented with hazard ratios (HR) and corresponding 95% confidence intervals (95%CI) using time on study (in years) as the underlying time scale following men from baseline screening until first episode of MACE, death from other causes, emigration, or end of follow-up on 31st December 2016 adjusting for age at baseline as a continuous co-variate. Analysis was accompanied with Kaplan-Meyer curves. The proportional hazards assumption was upheld for all analyses as assessed using log minus log plots. In order to explore associations with the metabolic disturbances separately, analyses were adjusted in two steps: Model 1: age, marital status, educational level, alcohol consumption and smoking, and Model 2: Model 1 + BMI, prevalent diabetes, fasting blood glucose, triglycerides, blood pressure, family history of CVD.

To avoid introducing immortal time bias in the survival analysis the men were grouped according to fatherhood status based on baseline status (start of follow up). Childlessness at the start of follow up (baseline) is related to age. In order to improve the use of childlessness as a proxy of infertility, only men 45 years or older were included in the analysis (N = 11343; 51.5% of all) classifying them according to fatherhood status at baseline.

Cases with prevalent MI (n = 97) or stroke (n = 25) were excluded from prospective analysis evaluating risk estimates for MACE and CVD mortality. The same model was used to study the risk of all-cause mortality, defining mortality as death before the end of follow-up.

We also used Cox regression analysis to calculate HRs for incident diabetes with the same adjustment models as described above. A total of 683 men had prevalent diabetes and were excluded from prospective analysis when evaluating the risk of developing diabetes.

As childlessness could be related to not having a partner rather than impaired fertility, a sensitivity analysis was performed including only married men [7].

All analyses were performed using SPSS v.25.0 (IBM corp., 2017, SPSS Statistics for Macintosh) using confidence intervals to interpret the results.

Results

Background characteristics

Entire cohort

A total of 2943 men remained childless and 17 729 were fathers. In total, 1773 men were excluded due to missing data as were 357 who had conflicting information on the number of children at time of baseline. The mean (SD) follow-up time for the cohort was 30.7 (9.4) years.

Men 45 years and older

A total of 2134 men 45 year or older at baseline were childless and 9209 were fathers. Of men categorized as childless at baseline fifteen fathered a child after the start of follow up. Mean (SD) age of the childless men was 48.9 (4.1) years compared to 48.7 (3.9) years among the fathers. Baseline characteristics are presented in Table 1.

Table 1. Socio-demographic and lifestyle characteristics of men older than 45 years with and without children at baseline.
Childless men (n = 2134) Fathers (n = 9209) p-value
Marital status 0.001
    • Never married (%) 43.8 1.3
    • Married, Divorced, Widower (%) 56.2 98.7
Level of education 0.01
    • No education (%) 11 4.1
    • Primary school (%) 62.6 63.6
    • Secondary school (%) 26.3 32.3
BMI (kg/m2): Mean (SD) 25.3 (3.8) 25 (3.2) 0.001
Alcohol consumption 0.03
    • Low risk alcohol consumption 51.9 48.9
    • Moderate risk alcohol habits 26.7 29.9
    • High risk alcohol habits 21.2 21.1
Present smoker 0.08
    • Non-smoker (%) 62.3 59.4
    • 10–20 cig. /day (%) 21.2 24.4
    • 20–30 cig. /day (%) 12.5 12.2
    • 30–40 cig./day (%) 2.7 2.9
    • More than 40 cig./day (%) 1.1 1.1
Age 48.9 (4.1) 48.7 (3.9) 0.08
Cholesterol (mmol/L) 5.81 (1.35) 5.76 (1.04) 0.06
Tryglicerides (mmol/L) 1.59 (0.95) 1.57 (1.01) 0.47
Serum glucose (mmol/L) 5.01 (1.19) 4.93 (1.07) 0.007
Family history of CVD (%) 0.61 0.58 0.68

Results presented with means (SD) and proportions (%). The results of the univariate analysis are presented with p-values.

Baseline morbidity

In the adjusted model, childless men presented with a worse metabolic profile than fathers at the baseline examination, with higher risk of high triglycerides, elevated fasting blood glucose and high blood pressure (Table 2). In the sub-analysis including only married men results remained unchanged (Table 2).

Table 2. Odds Ratio (OR) with 95% confidence intervals (95% CI) for metabolic syndrome components in childless men compared to fathers (reference group) at baseline adjusted for age, marital status, educational level, BMI, alcohol consumption, smoking.
Childlless men n/total (%) Fathers n/total (%) OR[95% CI]
Including all childless men Hyperglycaemia * 306 / 2114 (14.5) 1074/9176 (11.7) 1.27 [1.09–1.49]
Hyperlipidemia 687/ 2126 (32.3) 2816/9198 (30.6) 1.11 [0.98;1.25]
Elevated BP § 885/2114 (41.9) 3235/9201 (35.7) 1.26 [1.12;1.42]
Including only married childless men** Hyperglycaemia * 172/ 1118 (15.4) 1052/ 9057 (11.6) 1.29 [1.05;1.58]
Hyperlipidemia 383/1192(32.1) 2780/9079 (30.6) 1.16 [0.99;1.36]
Elevated BP § 492/ 1197 (41.3) 3193/9082 (35.2) 1.28 [1.10;1.49]

* Hyperglycemia defined as a fasting blood glucose level ≥ 5.6 mmol/L

‡ Hyperlipidemia defined as Triglycerides≥1.7 mmol/L

§ Elevated blood pressure (BP) defined by BP ≥130/85 mmHg

**The same adjustment model is used as described above excluding marriage status.

No increased risk of prevalent diabetes was observed among childless men than in fathers, (OR 1.15; 95% CI: 0.89–1.49). The childless men and fathers did not differ as considers prevalence MACE at baseline (OR 1.31; 95%CI: 0.68–2.50).

Prospective analysis

In the prospective analysis, men childless at baseline, in the fully adjusted model, presented with higher risk of cardiovascular mortality, HR: 1.33 (95% CI: 1.18–1.49) and all-cause mortality, HR 1.23 (95%CI: 1.14–1.33, Fig 1). After adjustment the childless men showed higher risk of incident cases of MACE, despite not significantly different from 1 (Table 3). The majority of risk estimates remained unchanged in the sub-analysis including only married childless men (Table 3).

Fig 1. Kaplan Meier survival curves of cardiovascular and all-cause mortality in childless men aged 45 years or older at baseline.as compared to fathers.

Fig 1

Red line denotes childless men, bue line–fathers. Log rank p value < 0.001.

Table 3. Hazard Ratios (HR) with 95%CI for Major Adverse Cardiovascular Events (MACE) and all-cause mortality in men childless at baseline relative to fathers at baseline.

Only men 45 years or older at baseline were included.

End points Childless N/% Fathers N/% Crude HR Model 1* Model 2**
Including all childless men MACE 930/44% 4047/44% 1.15 (1.06–1.23) 1.08(0.96–1.21) 1.04 (0.93–1.17)
Non-stroke MACE 715/34% 3022/33% 1.13 (1.04–1.25) 1.10 (0.96–1.25) 1.06 (0.93–1.21)
All-cause mortality 1651/77% 6423/69% 1.36 (1.28–1.44) 1.31 (1.21–1.44) 1.28 (1.18–1.40)
Cardiovascular mortality 724/34% 2498/27% 1.50 (1.37–1.65) 1.38 (1.20–1.58) 1.32 (1.15–1.52)
Including only married childless men *** MACE 52143% 4005/44% 1.1 (0.97–1.26) 1.07 (0.96–1.21) 1.04 (0.93–1.17)
Non-stroke MACE 403/34% 2991/33% 1.11 (0.97–1.26) 1.09 (0.96–1.25) 1.05 (0.92–1.20)
All-cause mortality 911/76% 6334/69% 1.34 (1.23–1.43) 1.31 (1.20–1.43) 1.28 (1.17–1.39)
Cardiovascular mortality 377/31% 2467/27% 1.41 (1.23–1.62) 1.37 (1.20–1.58) 1.32 (1.15–1.52)

* adjusted for: age, marital status, educational level, alcohol consumption, smoking (Model 1)

** adjusted for: Model 1 + BMI, family history of CVD prevalent diabetes, fasting blood glucose, triglycerides, blood pressure (continuous variables).

*** The same adjustment model is used as described above excluding marriage status.

For diabetes, in the prospective model, no increased risk was detected: HR 0.97 (95%CI: 0.83–1.13).

Discussion

In the present study, we found that childless men, at baseline health screening being on average slightly above 45 years, presented with statistically significantly higher risk of metabolic risk profile associated with MetS. Being childless was also associated with a higher risk of cardiovascular, and all-cause mortality when compared to men who were fathers. Results were robust to exclusion of unmarried men and thereby accounting for lack of reproductive opportunities. Interestingly, despite attenuation of HRs, the increase in mortality risks remained unchanged after adjustment for well known risk factors of CVD: BMI, prevalent diabetes, high fasting blood glucose, high triglycerides, high blood pressure, alcohol consumption, smoking, educational level and marriage status.

Thus, using childlessness as proxy for male infertility resulted in similar increased risk estimates in relation to metabolic and cardiovascular disease (CVD) as well all-cause mortality as previously reported for impaired semen quality, an established biological determinant of impaired male reproductive function [4].

The observed increased risk of MACE, CVD, and all–cause mortality among childless men is consistent with the majority of previous studies. What our study adds is the fact that mortality risks remain higher even after adjustment not only for available socio-economi, familial and behavioral factors as well as prevalent diabetes but also when adding to the model various metabolic parameters including glucose, triglycerides and hypertension. According to Eisenberg et al (2011) married childless men run a higher risk of dying from CVD after the age of 50 years [6]. A British study has evaluated the association between offspring number and prevalent CVD in both men and women [26]. Similar to our findings, they observed a higher risk of CVD among childless men compared to fathers. This study included 30% single men in the childless cohort which due to limited reproductive opportunities in those men might imply higher impact of adverse social factors rather than biological mechanisms related to the impaired reproductive function. A Swedish register-based study has previously reported that childless men have higher risk of dying from ischemic heart disease [27].

Despite previous reports showing higher prevalence of diabetes among childless men [7] our study failed to establish statistically significant association both in cross-sectional and prospective analysis.

Our findings seem to indicate that childlessnees, on top of well known risk factors of increased mortality due to CVD, is an independent predictor of this adverse life event. One can speculate whether this association is related to psychosocial mechanisms and/or a joint underlying biological cause of not fathering children and CVD. Available studies have failed to show a significant reduction in the risk of CVD mortality and all-cause mortality among childless men after adjusting for chronic conditions including intellectual disabilities, schizophrenia and early disability retirement [28]. Another study based on data form The Danish IVF register has suggested that the rate of psychiatric illness is of the same order of magnitude in biological parents as in childless individuals [29]. Another important aspect is lack of reproductive opportunities. In fact, 43% of childless men in our cohort were unmarried compared to 1.3% among fathers. Furthermore, men with lower educational level were shown to be overrepresented in the childless men group in previous studies from Sweden [38] suggesting a role of psycho-social status on parity. However, in a register-based analysis from Norway CVD mortality risk among childless men remained robust to adjustment for education, region of residence, population size municipality and marriage status [30]. By adjusting for educational level, and restricting the sensitivity analysis to only married men, we have tried to account for some of these non-biological mechanisms in our study.

Previous study [2] has demonstrated that increased mortality risk is associated with impaired semen quality, regardless of whether men investigated for infertility succeed to achieve parenthood or not. Thus, biological factors related to infertility seem also to play a role for the risk of adverse health events in those men.

Since family size can be directly linked to male fertility potential [16], an overrepresentation of sub-fertility among childless men is likely to be expected. The aforementioned associations between fertility and general health are complex and various biological mechanisms have been proposed, including shared genetic traits between metabolic and reproductive pathways or in utero exposure to adverse environmental factors in combination with maternal health issues during pregnancy affecting both fertility and cardiovascular health [14, 10, 31]. Both male infertility and low testosterone (T) levels can be regarded as consequences of testicular dysfunction, and positive association between these conditions have been identified in clinical cohorts [12]. Low T levels have been associated with metabolic disturbances, diabetes, cardiovascular disease and mortality risk [32, 33]. Therefore, low T levels and impaired androgenic state might be overrepresented among childless men and can serve as a plausible mediator of the established associations in our study. Atherosclerosis, a complex and not fully elucidated condition, is among the main risk traits for the majority of cardiovascular events. Low free T levels have been associated with carotid atherosclerosis, higher carotid intima media thickness and higher coronary artery calcium score [34, 35]. Apolipoprotein A1, a biomarker for subclinical atherosclerosis, was also found to be inversely related to T levels [36].

Our study has several strengths but also limitations. Comprehensive information from Swedish national registries allows for precise information on date and cause of death, emigration, and disease diagnosis. A mean follow-up of more than 30 years makes our cohort among the ones with the longest follow-up in comparison with other similar cohort studies. Our study is representative for the background population in Sweden’s third largest city allowing for inclusion and representation of men from all socioeconomic backgrounds. The meticulous data set at baseline provides an opportunity to adjust for diabetes, BMI, blood lipids, serum glucose, blood pressure, alcohol consumption and smoking.

One of the limitations is that we could neither account for the participants´ paternal intention, nor the partner’s fertility status and therefore the number of children cannot be regarded as an optimal proxy for reproductive potential. Fathers of adopted children, or those who have sired offspring with the help of assisted reproduction techniques, might have been included in the control group leading to misclassification bias. However, adoption rates in Sweden for the study period were relatively low and assisted reproduction technologies were not widely available before 1992 [3841] so we do not believe this to be a major concern/source of bias. Only one in four childless men in Sweden has been reported to be voluntary childless [38]. Therefore the risk of our sample to reflect voluntary childlessness is limited. Furthermore, it is unknown for how long the children lived with their fathers and in what family situation. Lonely fathers, for example, have been found to be at higher risk of CVD and mortality than cohabiting fathers [27]. Neither can marital strain be accounted for, a factor that might influence the number of children, and also independently relate to a higher risk of MACEs, CVD, and premature mortality [37]. Nevertheless, these types of misclassifications related to fertility, family dynamics and other unaccountable factors would rather tend to reduce the difference between the childless men and fathers and thus cannot explain the statistically significant differences reported by us.

Furthermore, in a prospective study, detecting a risk factor at the baseline examination might have given the opportunity to some of the men to adjust their lifestyle or receive treatment and thus possibly influence their risk of developing MACE and diabetes. Our study does not allow any conclusion as to whether the biological background to childlessness is a causative risk factor for CVD and mortality, or whether childlessness is a consequence of a disease which was yet subclinical at baseline.

Conclusion

This population-based study indicates that male childlessness represents an additional and independent risk factor of all cause and CVD-related mortality, and a risk condition of MACE when more conventional risk factors mediate the risk. This link may be related to psychosocial factors, but it also seems plausible to consider a common underlying biological factor predisposing to infertility and higher mortality risk for example genetics or early life programming. Childless middle-aged men should be considered as target population for prevention, although further research is needed to identify the underlying mechanisms in order to establish cause-related prophylactic measures.

Data Availability

The data underlying the results presented in the study can be regarded as potentially sensitive since the majority is derived from national registries. Dataset access is controlled by scientific committee. Request for access and applications can be sent to the principal investigators as described here: https://www.med.lu.se/malmoe_kost_cancer_och_malmoe_foerebyggande_medicin/malmoe_foerebyggande_medicin.

Funding Statement

The study was supported by grants: Interreg V funded program ReproUnion - all authors, joint European Association of Urology – ReproUnion scholarship - Angel Elenkov Research Council of Sweden Peter M Nillson The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Glazer CH, Bonde JP, Eisenberg ML, Giwercman A, Hærvig KK, Rimborg S, et al. Male Infertility and Risk of Nonmalignant Chronic Diseases: A Systematic Review of the Epidemiological Evidence. Semin Reprod Med. 2017;35(3):282–90. 10.1055/s-0037-1603568 [DOI] [PubMed] [Google Scholar]
  • 2.Jensen TK, Jacobsen R, Christensen K, Nielsen NC, Bostofte E. Good semen quality and life expectancy: a cohort study of 43,277 men. Am J Epidemiol. 2009;170(5):559–65. 10.1093/aje/kwp168 [DOI] [PubMed] [Google Scholar]
  • 3.Glazer CH, Bonde JP, Giwercman A, Vassard D, Pinborg A, Schmidt L, et al. Risk of diabetes according to male factor infertility: a register-based cohort study. Hum Reprod. 2017;32(7):1474–81. 10.1093/humrep/dex097 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Latif T, Kold Jensen T, Mehlsen J, Holmboe SA, Brinth L, Pors K, et al. Semen Quality as a Predictor of Subsequent Morbidity: A Danish Cohort Study of 4,712 Men With Long-Term Follow-up. Am J Epidemiol. 2017;186(8):910–7. 10.1093/aje/kwx067 [DOI] [PubMed] [Google Scholar]
  • 5.Elenkov A, Al-Jebari Y, Giwercman A. More Prevalent Prescription of Medicine for Hypertension and Metabolic Syndrome in Males from Couples Undergoing Intracytoplasmic Sperm Injection. Sci Rep. 2018;8(1):14521 10.1038/s41598-018-32813-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Eisenberg ML, Park Y, Hollenbeck AR, Lipshultz LI, Schatzkin A, Pletcher MJ. Fatherhood and the risk of cardiovascular mortality in the NIH-AARP Diet and Health Study. Hum Reprod. 2011;26(12):3479–85. 10.1093/humrep/der305 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Bungum AB, Glazer CH, Bonde JP, Nilsson PM, Giwercman A, Søgaard Tøttenborg S. Risk of metabolic disorders in childless men: a population-based cohort study. BMJ Open. 2018;8(8):e020293 10.1136/bmjopen-2017-020293 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Matzuk MM, Lamb DJ. The biology of infertility: research advances and clinical challenges. Nat Med. 2008;14(11):1197–213. 10.1038/nm.f.1895 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Liffner S, Hammar M, Bladh M, Nedstrand E, Martinez HR, Sydsjö G. Men becoming fathers by intracytoplasmic sperm injection were more often born small for gestational age. Asian J Androl. 2017;19(1):103–6. 10.4103/1008-682X.178848 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Skakkebaek NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod. 2001;16(5):972–8. 10.1093/humrep/16.5.972 [DOI] [PubMed] [Google Scholar]
  • 11.Schoeters GE, Den Hond E, Koppen G, Smolders R, Bloemen K, De Boever P, et al. Biomonitoring and biomarkers to unravel the risks from prenatal environmental exposures for later health outcomes. Am J Clin Nutr. 2011;94(6 Suppl):1964S–9S. 10.3945/ajcn.110.001545 [DOI] [PubMed] [Google Scholar]
  • 12.Bobjer J, Bogefors K, Isaksson S, Leijonhufvud I, Åkesson K, Giwercman YL, et al. High prevalence of hypogonadism and associated impaired metabolic and bone mineral status in subfertile men. Clin Endocrinol (Oxf). 2016;85(2):189–95. [DOI] [PubMed] [Google Scholar]
  • 13.Vlachopoulos C, Pietri P, Ioakeimidis N, Aggelis A, Terentes-Printzios D, Abdelrasoul M, et al. Inverse association of total testosterone with central haemodynamics and left ventricular mass in hypertensive men. Atherosclerosis. 2016;250:57–62. 10.1016/j.atherosclerosis.2016.04.018 [DOI] [PubMed] [Google Scholar]
  • 14.Rao PM, Kelly DM, Jones TH. Testosterone and insulin resistance in the metabolic syndrome and T2DM in men. Nat Rev Endocrinol. 2013;9(8):479–93. 10.1038/nrendo.2013.122 [DOI] [PubMed] [Google Scholar]
  • 15.Bentmar Holgersson M, Landgren F, Rylander L, Lundberg Giwercman Y. Mortality Is Linked to Low Serum Testosterone Levels in Younger and Middle-aged Men. Eur Urol. 2017;71(6):991–2. 10.1016/j.eururo.2016.11.036 [DOI] [PubMed] [Google Scholar]
  • 16.Joffe M, Key J, Best N, Jensen TK, Keiding N. The role of biological fertility in predicting family size. Hum Reprod. 2009;24(8):1999–2006. 10.1093/humrep/dep087 [DOI] [PubMed] [Google Scholar]
  • 17.Breyer BN, Smith JF, Shindel AW, Sharlip ID, Eisenberg ML. The impact of infertility on family size in the USA: data from the National Survey of Family Growth. Hum Reprod. 2010;25(9):2360–5. 10.1093/humrep/deq152 [DOI] [PubMed] [Google Scholar]
  • 18.McAlister FA, Wiebe N, Ronksley PE, Healey JS. Although non-stroke outcomes are more common, stroke risk scores can be used for prediction in patients with atrial fibrillation. Int J Cardiol. 2018;269:145–51. 10.1016/j.ijcard.2018.07.128 [DOI] [PubMed] [Google Scholar]
  • 19.Trell E. Community-based preventive medical department for individual risk factor assessment and intervention in an urban population. Prev Med. 1983;12(3):397–402. 10.1016/0091-7435(83)90248-7 [DOI] [PubMed] [Google Scholar]
  • 20.Berglund G, Eriksson KF, Israelsson B, Kjellström T, Lindgärde F, Mattiasson I, et al. Cardiovascular risk groups and mortality in an urban swedish male population: the Malmö Preventive Project. J Intern Med. 1996;239(6):489–97. 10.1046/j.1365-2796.1996.483819000.x [DOI] [PubMed] [Google Scholar]
  • 21.Berglund G, Nilsson P, Eriksson KF, Nilsson JA, Hedblad B, Kristenson H, et al. Long-term outcome of the Malmö preventive project: mortality and cardiovascular morbidity. J Intern Med. 2000;247(1):19–29. 10.1046/j.1365-2796.2000.00568.x [DOI] [PubMed] [Google Scholar]
  • 22.Smith JG, Platonov PG, Hedblad B, Engström G, Melander O. Atrial fibrillation in the Malmö Diet and Cancer study: a study of occurrence, risk factors and diagnostic validity. Eur J Epidemiol. 2010;25(2):95–102. 10.1007/s10654-009-9404-1 [DOI] [PubMed] [Google Scholar]
  • 23.Christensson A, Melander O, Fjellstedt E, Ohlson-Andersson M. Family history of myocardial infarction increases risk of renal dysfunction in middle age. Am J Nephrol. 2014;39(2):85–91. 10.1159/000358259 [DOI] [PubMed] [Google Scholar]
  • 24.af Sillén U, Nilsson JA, Månsson NO, Nilsson PM. Self-rated health in relation to age and gender: influence on mortality risk in the Malmö Preventive Project. Scand J Public Health. 2005;33(3):183–9. 10.1080/14034940410019235 [DOI] [PubMed] [Google Scholar]
  • 25.Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C, Association AH, et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109(3):433–8. 10.1161/01.CIR.0000111245.75752.C6 [DOI] [PubMed] [Google Scholar]
  • 26.Lawlor DA, Emberson JR, Ebrahim S, Whincup PH, Wannamethee SG, Walker M, et al. Is the association between parity and coronary heart disease due to biological effects of pregnancy or adverse lifestyle risk factors associated with child-rearing? Findings from the British Women's Heart and Health Study and the British Regional Heart Study. Circulation. 2003;107(9):1260–4. 10.1161/01.cir.0000053441.43495.1a [DOI] [PubMed] [Google Scholar]
  • 27.Ringbäck Weitoft G, Burström B, Rosén M. Premature mortality among lone fathers and childless men. Soc Sci Med. 2004;59(7):1449–59. 10.1016/j.socscimed.2004.01.026 [DOI] [PubMed] [Google Scholar]
  • 28.Einiö E, Nisén J, Martikainen P. Number of children and later-life mortality among Finns born 1938–50. Popul Stud (Camb). 2016;70(2):217–38. [DOI] [PubMed] [Google Scholar]
  • 29.Agerbo E, Mortensen PB, Munk-Olsen T. Childlessness, parental mortality and psychiatric illness: a natural experiment based on in vitro fertility treatment and adoption. J Epidemiol Community Health. 2013;67(4):374–6. 10.1136/jech-2012-201387 [DOI] [PubMed] [Google Scholar]
  • 30.Grundy E, Kravdal O. Fertility history and cause-specific mortality: a register-based analysis of complete cohorts of Norwegian women and men. Soc Sci Med. 2010;70(11):1847–57. 10.1016/j.socscimed.2010.02.004 [DOI] [PubMed] [Google Scholar]
  • 31.Bonde JP, Flachs EM, Rimborg S, Glazer CH, Giwercman A, Ramlau-Hansen CH, et al. The epidemiologic evidence linking prenatal and postnatal exposure to endocrine disrupting chemicals with male reproductive disorders: a systematic review and meta-analysis. Hum Reprod Update. 2016;23(1):104–25. 10.1093/humupd/dmw036 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Bogefors C, Isaksson S, Bobjer J, Kitlinski M, Leijonhufvud I, Link K, et al. Hypogonadism in testicular cancer patients is associated with risk factors of cardiovascular disease and the metabolic syndrome. Andrology. 2017;5(4):711–7. 10.1111/andr.12354 [DOI] [PubMed] [Google Scholar]
  • 33.Khaw KT, Dowsett M, Folkerd E, Bingham S, Wareham N, Luben R, et al. Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation. 2007;116(23):2694–701. 10.1161/CIRCULATIONAHA.107.719005 [DOI] [PubMed] [Google Scholar]
  • 34.Svartberg J, von Mühlen D, Mathiesen E, Joakimsen O, Bønaa KH, Stensland-Bugge E. Low testosterone levels are associated with carotid atherosclerosis in men. J Intern Med. 2006;259(6):576–82. 10.1111/j.1365-2796.2006.01637.x [DOI] [PubMed] [Google Scholar]
  • 35.Khazai B, Golden SH, Colangelo LA, Swerdloff R, Wang C, Honoris L, et al. Association of endogenous testosterone with subclinical atherosclerosis in men: the multi-ethnic study of atherosclerosis. Clin Endocrinol (Oxf). 2016;84(5):700–7. [DOI] [PubMed] [Google Scholar]
  • 36.Rezanezhad B, Borgquist R, Willenheimer R, Elzanaty S. Association between serum levels of testosterone and biomarkers of subclinical atherosclerosis. Aging Male. 2018;21(3):182–6. 10.1080/13685538.2017.1412422 [DOI] [PubMed] [Google Scholar]
  • 37.Eaker ED, Sullivan LM, Kelly-Hayes M, D'Agostino RB, Benjamin EJ. Marital status, marital strain, and risk of coronary heart disease or total mortality: the Framingham Offspring Study. Psychosom Med. 2007;69(6):509–13. 10.1097/PSY.0b013e3180f62357 [DOI] [PubMed] [Google Scholar]
  • 38.Chudnovskaya, M (2017),”Trends in Childlessness among Highly Educated Men in Sweden”, i Chudnovskaya, M, Higher Education and Family Formation: A Story of Swedish Educational Expansion, PhD thesis in Sociology, Stockholm University, Sweden, 2017
  • 39.Statistics Sweden (SCB). Childbearing patterns of different generations, 2011.
  • 40.Statistics Sweden (SCB). Internationella adoptioner minskar, 2013.
  • 41.Gottvall K, Lundqvist E, Graviditeter KK. Förlossningar och nyfödda barn. Medicinska födelseregistret 1973–2014 (Medical Birth Register). Assisterad befruktning 1991–2013, 2015. [Google Scholar]

Decision Letter 0

Ying-Mei Feng

17 Dec 2019

PONE-D-19-18778

Male Childlessness as Independent Predictor of Risk of Cardiovascular and All-cause Mortality: A Population-based Cohort Study with more than 30 years follow-up

PLOS ONE

Dear Dr. Elenkov,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

In this population-based cohort, Angel Elenkov et al evaluated the association between male childlessness and the risk of MACE, cardiovascular mortality, all-cause mortality, and incident diabetes. Authors found that, compared with men with children, childless men were featured with higher fasting blood glucose, triglycerides and blood pressure at the baseline. After adjusting for some co-variables, male childlessness was significantly associated with higher risk of cardiovascular death (HR=1.33) and all-cause death (HR=1.23). Whereas, childlessness was non-significantly associated with lower incidence of diabetes (HR=0.97). Overall, the study is interesting and the quality of this manuscript needs to be improved.

Major concerns:

1.There was no information on why these men didn’t have a child, thus, I wonder whether it was accurate to use the male childlessness as a proxy of impaired fertility.

2.Some important co-variables, such as family history of cardiovascular disease and economic level, should enter into the regression model. Fasting blood glucose, triglycerides and blood pressure should be treated as continuous variable.

3.What’s the rationale of conducting sensitivity analysis? My suggestion is adding the interaction of male childlessness and marital status in the model.

4.Table 1 should present the basic characteristics of people included in the final analysis, not that of entire people of the cohort. Please modify the tables style to make them meet the general requirements of academic publication. 

5.Please check the diagnosis criteria of diabetes.

6.The writing needs to be properly simplified.

We would appreciate receiving your revised manuscript by Jan 30 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Ying-Mei Feng

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

PLoS One. 2020 Sep 3;15(9):e0237422. doi: 10.1371/journal.pone.0237422.r002

Author response to Decision Letter 0


29 Jan 2020

Comments to the Author:

In this population-based cohort, Angel Elenkov et al evaluated the association between male childlessness and the risk of MACE, cardiovascular mortality, all-cause mortality, and incident diabetes. Authors found that, compared with men with children, childless men were featured with higher fasting blood glucose, triglycerides and blood pressure at the baseline. After adjusting for some co-variables, male childlessness was significantly associated with higher risk of cardiovascular death (HR=1.33) and all-cause death (HR=1.23). Whereas, childlessness was non-significantly associated with lower incidence of diabetes (HR=0.97). Overall, the study is interesting and the quality of this manuscript needs to be improved.

Major concerns:

1.There was no information on why these men didn’t have a child, thus, I wonder whether it was accurate to use the male childlessness as a proxy of impaired fertility.

Reply: The issue raised by the reviewer is highly relevant and has also been addressed in the Discussion section of the original version of the manuscript. The group of childless men represent a mixture of men with lowered fertility, those with a sub fertile partner and also subjects who decided not to father children. The registry data we use dates back to the first half of the 1970´s. The possibilities for fertility treatment in men at that time were very limited if present. The modern methods of assisted reproduction are developed in the beginning of the 1990´s. Before that men with a very low fertility potential did not have the possibility to use, for example, intracytoplasmic sperm injection to achieve fertilization and pregnancy. Presumably a big majority of men with infertility before the 1990´s have thus remained childless. We agree that childlessness as a proxy for male infertility has some limitations, for example the fact that we could not account for the participants´ paternal intention, nor the partner’s fertility status, marital strain etc. However, a nation-wide statistical data from Sweden have shown that only one in four childless men are voluntarily childless (Statistics Sweden, SCB: Childbearing patterns of different generations, 2011). This information has now been added to the Discussion part of the manuscript. Fathers of adopted children, or those who have sired offspring with the help of assisted reproduction techniques (ART), might have been included in the control group leading to misclassification bias. Nevertheless, these types of misclassifications related to fertility, family dynamics and other unaccountable factors would rather tend to reduce the difference between the childless men and fathers and thus cannot explain the statistically significant differences reported by us. Furthermore, we regard the 30 years of follow-up, which is the longest available among similar studies, as a major strength of our analysis.

2. Some important co-variables, such as family history of cardiovascular disease and economic level, should enter into the regression model. Fasting blood glucose, triglycerides and blood pressure should be treated as continuous variable.

Reply: We have changed our analysis according to reviewer’s suggestions. We included a separate co-variate “called family history for CVD” (p.8, l.158 - 161): “… A positive family history for CVD was defined as reporting having at least one first-degree relative with MI before the age of 60 years as described previously (24). No family history was defined as no reported first‐degree relatives with MI before 60 years, or no answer in the questionnaire…”

We have treated fasting blood glucose, triglycerides and blood pressure as continuous variables. Data on economic level of the subjects is not available from our data set. Our results are not significantly changed and are summarized in the revised table (p.15 l.290 - 298.)

3.What’s the rationale of conducting sensitivity analysis? My suggestion is adding the interaction of male childlessness and marital status in the model.

Reply: The rational for including this sensitivity analysis refers to the point of criticism raised by the reviewer in item 1. By excluding men who remained unmarried we reduce the proportion of voluntarily childless men and men without opportunity to reproduce in the “exposed” group and to exclude non-marriage as cause of increased cardiovascular mortality risk in childless men. Our data seem to confirm that this risk increase is related to childlessness per se and not to being married or not. The suggestion of including interaction analysis is interesting, in case the hypothesis that the association between childlessness and increased mortality is modulated by marital status. This was not part of our hypothesis, why such interaction analysis was not included in the original version of the manuscript. However, we have performed these calculations:

There was a statistically significant interaction between childlessness and marital status in the model evaluating the risk for all-cause mortality (p=0.037) in the partially adjusted model (model 1). However, the interaction was no longer statistically significant in the fully adjusted model 2 (p=0.95). Furthermore, the interaction was not statistically significant in the other analysis evaluating MACEs and CVD mortality in any of the models (data not presented).

As mentioned above, we have omitted this analysis because it was not part of our hypothesis. If the Reviewer/Editor wishes it to be a part of the manuscript, we can easily implement it into the final version. However, for reason mentioned above, we suggest that even the sensitivity analysis is kept as it is now.

4. Table 1 should present the basic characteristics of people included in the final analysis, not that of entire people of the cohort. Please modify the tables style to make them meet the general requirements of academic publication.

Reply: The table has been modified according to the reviewer’s suggestion (p.12).

5. Please check the diagnosis criteria of diabetes.

Reply: A technical mistake on line 154: “…had fasting blood glucose > 6.5” was corrected to: “…had fasting blood glucose > 5.6...”

6.The writing needs to be properly simplified.

Reply: We have now taken a second look in the text in order to make the writing concise and simple as much as possible. We would be however grateful if the editors/reviewers point to additional parts of the manuscript which may need re-writing.

Attachment

Submitted filename: Answer_reviewers-PlosOne_revsion2020_01_28.docx

Decision Letter 1

Ying-Mei Feng

22 Apr 2020

PONE-D-19-18778R1

Male Childlessness as Independent Predictor of Risk of Cardiovascular and All-cause Mortality: A Population-based Cohort Study with more than 30 years follow-up

PLOS ONE

Dear Dr. Elenkov,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

1. Please describe the charactersitics of age, familiy history of CVD, and biochemical factors in the Table 1.  Also, please add the univariate analysis to indicate whether there were significant difference between the two groups in the Table 1. 

2. As the last row of Table 2 shows,  the proportion of elevated BP in the two groups was equal, but the OR was more than 1.0. Please check it.

3. I think Table 2 should show the association of childlessness with metabolic features among participants included in the final analysis (45 years or older), rather than among participants of the entire cohort.  Instead of presenting the reference group using a column, adding this information at the footnote would be better. The column of OR (95% CI) was supposed to be listed on the end of the table. 

4. In Table 3, the three columns of HR (95% CI) should be listed on the right side of the two columns of endpoints incidence. Considering the “total” number of "Childless"/ "Fathers" was fixed in most rows, it should not be marked repetedly, which would simplify the table.

5. Both in Table 2 and Table 3, the first column indicating the different range of paritcipants included in the regression, and please keep the words of the first column consistent.

We would appreciate receiving your revised manuscript by Jun 06 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Ying-Mei Feng

Academic Editor

PLOS ONE

PLoS One. 2020 Sep 3;15(9):e0237422. doi: 10.1371/journal.pone.0237422.r004

Author response to Decision Letter 1


12 May 2020

Comments raised during the review process:

1. Please describe the charactersitics of age, familiy history of CVD, and biochemical factors in the Table 1. Also, please add the univariate analysis to indicate whether there were significant difference between the two groups in the Table 1.

2. As the last row of Table 2 shows, the proportion of elevated BP in the two groups was equal, but the OR was more than 1.0. Please check it.

3. I think Table 2 should show the association of childlessness with metabolic features among participants included in the final analysis (45 years or older), rather than among participants of the entire cohort. Instead of presenting the reference group using a column, adding this information at the footnote would be better. The column of OR (95% CI) was supposed to be listed on the end of the table.

4. In Table 3, the three columns of HR (95% CI) should be listed on the right side of the two columns of

endpoints incidence. Considering the “total” number of "Childless"/ "Fathers" was fixed in most rows, it should not be marked repetedly, which would simplify the table.

5. Both in Table 2 and Table 3, the first column indicating the different range of paritcipants included in the regression, and please keep the words of the first column consistent.

Reply:

We have made all corrections to all tables as proposed. A number of calculations were also performed with new data included to the tables. The main results and conclusions from our study are not changed.

Attachment

Submitted filename: Answer_reviewers-PlosOne_revsion2020_05_06.docx

Decision Letter 2

Ying-Mei Feng

28 Jul 2020

Male Childlessness as Independent Predictor of Risk of Cardiovascular and All-cause Mortality: A Population-based Cohort Study with more than 30 years follow-up

PONE-D-19-18778R2

Dear Dr. Elenkov,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Ying-Mei Feng

Academic Editor

PLOS ONE

Acceptance letter

Ying-Mei Feng

19 Aug 2020

PONE-D-19-18778R2

Male Childlessness as Independent Predictor of Risk of Cardiovascular and All-cause Mortality: A Population-based Cohort Study with more than 30 years follow-up

Dear Dr. Elenkov:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr Ying-Mei Feng

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Answer_reviewers-PlosOne_revsion2020_01_28.docx

    Attachment

    Submitted filename: Answer_reviewers-PlosOne_revsion2020_05_06.docx

    Data Availability Statement

    The data underlying the results presented in the study can be regarded as potentially sensitive since the majority is derived from national registries. Dataset access is controlled by scientific committee. Request for access and applications can be sent to the principal investigators as described here: https://www.med.lu.se/malmoe_kost_cancer_och_malmoe_foerebyggande_medicin/malmoe_foerebyggande_medicin.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES